824 related articles for article (PubMed ID: 17979650)
21. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
Al Asmari AK; Ullah Z; Tariq M; Fatani A
Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
[TBL] [Abstract][Full Text] [Related]
22. The significance of drug-to-lipid ratio to the development of optimized liposomal formulation.
Chountoulesi M; Naziris N; Pippa N; Demetzos C
J Liposome Res; 2018 Sep; 28(3):249-258. PubMed ID: 28627268
[TBL] [Abstract][Full Text] [Related]
23. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
[TBL] [Abstract][Full Text] [Related]
24. Liposomes in ultrasonic drug and gene delivery.
Huang SL
Adv Drug Deliv Rev; 2008 Jun; 60(10):1167-76. PubMed ID: 18479776
[TBL] [Abstract][Full Text] [Related]
25. Updates on the use of liposomes for active tumor targeting in cancer therapy.
Yan W; Leung SS; To KK
Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
[TBL] [Abstract][Full Text] [Related]
26. Design of liposomal formulations for cell targeting.
Nogueira E; Gomes AC; Preto A; Cavaco-Paulo A
Colloids Surf B Biointerfaces; 2015 Dec; 136():514-26. PubMed ID: 26454541
[TBL] [Abstract][Full Text] [Related]
27. Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs.
Song G; Wu H; Yoshino K; Zamboni WC
J Liposome Res; 2012 Sep; 22(3):177-92. PubMed ID: 22332871
[TBL] [Abstract][Full Text] [Related]
28. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies.
Goren D; Horowitz AT; Zalipsky S; Woodle MC; Yarden Y; Gabizon A
Br J Cancer; 1996 Dec; 74(11):1749-56. PubMed ID: 8956788
[TBL] [Abstract][Full Text] [Related]
29. Drug delivery systems: entering the mainstream.
Allen TM; Cullis PR
Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
[TBL] [Abstract][Full Text] [Related]
30. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
31. A new method for liposome preparation using a membrane contactor.
Jaafar-Maalej C; Charcosset C; Fessi H
J Liposome Res; 2011 Sep; 21(3):213-20. PubMed ID: 20860451
[TBL] [Abstract][Full Text] [Related]
32. Liposomes as biocompatible and smart delivery systems - the current state.
Dymek M; Sikora E
Adv Colloid Interface Sci; 2022 Nov; 309():102757. PubMed ID: 36152374
[TBL] [Abstract][Full Text] [Related]
33. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
Allen TM; Mumbengegwi DR; Charrois GJ
Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
[TBL] [Abstract][Full Text] [Related]
34. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Schroeder A; Kost J; Barenholz Y
Chem Phys Lipids; 2009 Nov; 162(1-2):1-16. PubMed ID: 19703435
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of gemcitabine liposome injections.
Zhou Q; Liu L; Zhang D; Fan X
Pharmazie; 2012 Oct; 67(10):844-7. PubMed ID: 23136718
[TBL] [Abstract][Full Text] [Related]
37. Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.
Ranade VV
J Clin Pharmacol; 1989 Aug; 29(8):685-94. PubMed ID: 2674208
[TBL] [Abstract][Full Text] [Related]
38. Microfluidics based manufacture of liposomes simultaneously entrapping hydrophilic and lipophilic drugs.
Joshi S; Hussain MT; Roces CB; Anderluzzi G; Kastner E; Salmaso S; Kirby DJ; Perrie Y
Int J Pharm; 2016 Nov; 514(1):160-168. PubMed ID: 27863660
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of bioactive transfer through liposomal bilayers.
Maherani B; Arab-Tehrani E; Linder M
Curr Drug Targets; 2011 Apr; 12(4):531-45. PubMed ID: 20863276
[TBL] [Abstract][Full Text] [Related]
40. From conventional to stealth liposomes: a new Frontier in cancer chemotherapy.
Cattel L; Ceruti M; Dosio F
J Chemother; 2004 Nov; 16 Suppl 4():94-7. PubMed ID: 15688621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
